Indian nutraceuticals attract big pharma

By Shane Starling

- Last updated on GMT

The growing Indian nutraceuticals market is attracting the attention of pharmaceuticals players such as GlaxoSmithKline, Dabur, Cadila Healthcare and Novartis, according to Indian press reports.

The Indian functional foods market is estimated to be growing at about 12-15 per cent according to various estimates, as the effects of western diets, increased personal incomes, rising medical costs, better health education and ageing populations take hold.

Product launches include a healthy malt drink called Viva from GlaxoSmithKline Consumer Healthcare, British Biologicals with whey sports supplements and a carotenoid range from Parry Nutraceuticals.

“People today are becoming health-conscious and are realising the need for dietary supplements to help them cope with the fast-changing pace of life, which has put them at the risk of diabetes, cholesterol, heart ailments, arthritis and so on,”​ Dr Kamal G Nath, a nutritionist at the University of Agricultural Sciences in Bangalore, told FnBnews.

Dr V Prakash, director at the Central Food Technological Research Institute (CFTRI) in Mysore, said extracts such as those from wheat grass, whey and mushroom were being used by food and food supplement manufacturers, as well as in the form of stand-alone take-home ingredients.

“In these cases the nutraceutical is separated from a food and sold in dosage form,”​ added Dr Prakash.

As western diet and lifestyle habits spread in India, associated diseases are also on the rise such as diabetes, cholesterol and hypertension.

“This is where nutraceuticals are known to play a major role in controlling ill-health condition,”​ said Dr K Shantha Kumar, also from the Bangladore’s University of Agricultural Sciences. “It makes people opt for protein supplements and multi-mineral supplements.”

Other companies active in the nutraceutical area include Sami Labs, British Biologicals, Elder Pharma, Ranbaxy, Raptakos, Avesthagen, Paras, Ce Chem and Tablets India.


But market researcher, Frost & Sullivan, noted of the Indian market in a recent report:

“Multinational companies have found the Indian market very challenging in the past owing to supply shortages, poor cold chain, storage facilities, poor infrastructure, and underdeveloped and complicated distribution channels,”​ it said.

“Performance in the food and beverage probiotic market is still dominated by issues in strain stability, low shelf life of products, and the development of probiotic application technology.”

Related news

Show more

Related products

show more

Support a new era of active lifestyle consumers

Support a new era of active lifestyle consumers

Content provided by Lonza | 05-Nov-2024 | Product Brochure

Mobility is taking center stage for a new generation of consumers who understand that mobility and joint health are inextricably linked to long-term quality...

Explore the scientific foundations of Nextida™ GC

Explore the scientific foundations of Nextida™ GC

Content provided by Rousselot | 01-Nov-2024 | White Paper

The first commercialised ingredient in the Nextida platform, a range of specific collagen peptide compositions with targeted health benefits, Nextida™...

Searching for a High-Purity Low-Dose Ceramide?

Searching for a High-Purity Low-Dose Ceramide?

Content provided by Maypro | 28-Oct-2024 | Infographic

Ceramides are naturally occurring lipids that enable water retention and healthy functioning of the epidermal layers. As we age, the skin loses ceramides...

Related suppliers

Follow us

Products

View more

Webinars